These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22453137)

  • 1. Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.
    Panlilio LV; Justinova Z; Mascia P; Pistis M; Luchicchi A; Lecca S; Barnes C; Redhi GH; Adair J; Heishman SJ; Yasar S; Aliczki M; Haller J; Goldberg SR
    Neuropsychopharmacology; 2012 Jul; 37(8):1838-47. PubMed ID: 22453137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors.
    Mascia P; Pistis M; Justinova Z; Panlilio LV; Luchicchi A; Lecca S; Scherma M; Fratta W; Fadda P; Barnes C; Redhi GH; Yasar S; Le Foll B; Tanda G; Piomelli D; Goldberg SR
    Biol Psychiatry; 2011 Apr; 69(7):633-41. PubMed ID: 20801430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors.
    Luchicchi A; Lecca S; Carta S; Pillolla G; Muntoni AL; Yasar S; Goldberg SR; Pistis M
    Addict Biol; 2010 Jul; 15(3):277-88. PubMed ID: 20477753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
    Jackson A; Bagdas D; Muldoon PP; Lichtman AH; Carroll FI; Greenwald M; Miles MF; Damaj MI
    Neuropharmacology; 2017 May; 118():38-45. PubMed ID: 28279662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse.
    Justinova Z; Panlilio LV; Moreno-Sanz G; Redhi GH; Auber A; Secci ME; Mascia P; Bandiera T; Armirotti A; Bertorelli R; Chefer SI; Barnes C; Yasar S; Piomelli D; Goldberg SR
    Neuropsychopharmacology; 2015 Aug; 40(9):2185-97. PubMed ID: 25754762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward.
    Sagheddu C; Scherma M; Congiu M; Fadda P; Carta G; Banni S; Wood JT; Makriyannis A; Malamas MS; Pistis M
    Neuropharmacology; 2019 Jan; 144():327-336. PubMed ID: 30439418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuating Nicotine Reinforcement and Relapse by Enhancing Endogenous Brain Levels of Kynurenic Acid in Rats and Squirrel Monkeys.
    Secci ME; Auber A; Panlilio LV; Redhi GH; Thorndike EB; Schindler CW; Schwarcz R; Goldberg SR; Justinova Z
    Neuropsychopharmacology; 2017 Jul; 42(8):1619-1629. PubMed ID: 28139681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens.
    Sziráki I; Sershen H; Hashim A; Lajtha A
    Neurochem Res; 2002 Mar; 27(3):253-61. PubMed ID: 11958525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release.
    Nisell M; Nomikos GG; Svensson TH
    Pharmacol Toxicol; 1994 Dec; 75(6):348-52. PubMed ID: 7534921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys.
    Justinova Z; Panlilio LV; Secci ME; Redhi GH; Schindler CW; Cross AJ; Mrzljak L; Medd A; Shaham Y; Goldberg SR
    Biol Psychiatry; 2015 Oct; 78(7):452-62. PubMed ID: 25802079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.
    Scherma M; Justinová Z; Zanettini C; Panlilio LV; Mascia P; Fadda P; Fratta W; Makriyannis A; Vadivel SK; Gamaleddin I; Le Foll B; Goldberg SR
    Br J Pharmacol; 2012 Apr; 165(8):2539-48. PubMed ID: 21557729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine and behavioral sensitization.
    Mao D; McGehee DS
    J Mol Neurosci; 2010 Jan; 40(1-2):154-63. PubMed ID: 19669944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
    Paterson NE; Balfour DJ; Markou A
    Eur J Neurosci; 2007 May; 25(10):3099-108. PubMed ID: 17561823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects.
    Tan H; Bishop SF; Lauzon NM; Sun N; Laviolette SR
    Neuropharmacology; 2009 Mar; 56(4):741-51. PubMed ID: 19133278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo.
    Fu Y; Matta SG; Gao W; Sharp BM
    Neuroscience; 2000; 101(2):369-75. PubMed ID: 11074160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Route of nicotine administration influences in vivo dopamine neuron activity: habituation, needle injection, and cannula infusion.
    Dong Y; Zhang T; Li W; Doyon WM; Dani JA
    J Mol Neurosci; 2010 Jan; 40(1-2):164-71. PubMed ID: 19714495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.
    Erhardt S; Schwieler L; Engberg G
    Synapse; 2002 Mar; 43(4):227-37. PubMed ID: 11835517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study.
    Yin R; French ED
    Brain Res Bull; 2000 Apr; 51(6):507-14. PubMed ID: 10758341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.
    Schilström B; Nomikos GG; Nisell M; Hertel P; Svensson TH
    Neuroscience; 1998 Feb; 82(3):781-9. PubMed ID: 9483535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area.
    Laviolette SR; van der Kooy D
    Mol Psychiatry; 2003 Jan; 8(1):50-9, 9. PubMed ID: 12556908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.